Abstract

Objectives
This study evaluated the efficacy of Polyethylene glycol 4000 for fecal disimpaction in children with cerebral palsy.
Materials & Methods
A randomized control trial study was conducted on children with cerebral palsy between February – March 2017 in the pediatric neurology outpatient clinic Dr. Soetomo Hospital. Children aged 2-16 years with fecal impaction randomly assigned into polyethylene glycol 4000 (PEG 4000) and saline enema group. Polyethylene glycol 4000 was given at a dosage of 0.7 g/kg and enema using normal saline 15ml/kg twelve hourly. Constipation was diagnosed using ROME IV criteria, and abdominal palpation identified fecal impaction. Efficacy was evaluated by clinical observation and adverse symptom monitoring. Data were analyzed by statistical software using an independent t-test (p<0,05).

Results

Thirty-two children were randomized into the study. Muscle relaxant was discovered in 17/32 patients. Sex, age, and body weight were not statistically different between groups. The resolution of fecal  impaction was significantly different between PEG 4000 and saline enema (21.69 hours and 39 hours respectively; p=0.001). Application of muscle relaxant and severity of the disease did not involve treatment efficacy. There was no adverse symptom reported during treatment

Conclusion
Polyethylene glycol 4000 results in fecal disimpaction faster than enema in constipated children with cerebral palsy

 

 

Keywords: cerebral palsy constipation fecal impaction PEG4000 Child health References

1. Del Giudice E, Staiano A, Capano G, Romano A, Florimonte L, Miele E, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain Dev 1999 Jul;21(5):307–11. Available from: https://linkinghub.elsevier.com/retrieve/pii/S038776049900025X
2. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impairment: Oxford Feeding Study. Dev Med Child Neurol 2000 Oct;42(10):S0012162200001249. Available from: http://doi.wiley.com/10.1017/S0012162200001249
3. Veugelers R, Benninga MA, Calis EAC, Willemsen SP, Evenhuis H, Tibboel D, et al. Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy. Dev Med Child Neurol 2010;52(9):e216-21. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20497454
4. Elawad MA, Sullivan PB. Management of constipation in children with disabilities. Dev Med Child Neurol 2001 Dec 18;43(12):829. Available from: http://doi.wiley.com/10.1017/S0012162201001505
5. Agarwal J. Chronic Constipation. Indian J Pediatr 2013 14;80(12):1021–5. Available from: http://link.springer.com/10.1007/s12098-013-1133-5
6. Zeevenhooven J, Koppen IJN, Benninga MA. The New Rome IV Criteria for Functional Gastrointestinal Disorders in Infants and Toddlers. Pediatr Gastroenterol Hepatol Nutr 2017;20(1):1.
7. Youssef NN, Peters JM, Henderson W, Shultz-Peters S, Lockhart DK, Di Lorenzo C. Dose response of PEG 3350 for the treatment of childhood fecal impaction. J Pediatr. 2002;141(3):410–4.
8. Candy DCA, Edwards D, Geraint M. Treatment of Faecal Impaction with Polyethelene Glycol Plus Electrolytes (PGE + E) Followed by a Double-blind Comparison of PEG + E Versus Lactulose as Maintenance Therapy. J Pediatr Gastroenterol Nutr 2006 Jul;43(1):65–70. Available from: https://journals.lww.com/00005176-200607000-00011
9. Guest JF, Candy DCA, Clegg JP, Edwards D, Helter MT, Dale AK, et al. Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales. Curr Med Res Opin 2007 Sep 9;23(9):2213–25. Available from: http://www.tandfonline.com/doi/full/10.1185/030079907X210462
10. Candy D, Belsey J. Macrogol (polyethylene glycol) laxatives in children with functional constipation and faecal impaction: a systematic review. Arch Dis Child 2008 Sep 18;94(2):156–60. Available from: https://adc.bmj.com/lookup/doi/10.1136/adc.2007.128769
11. Bernier JJ, Donazzolo Y. [Effect of low-dose polyethylene glycol 4000 on fecal consistency and dilution water in healthy subjects]. Gastroenterol Clin Biol 1997;21(1):7–11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8761138
12. Bekkali N-L-H, van den Berg M-M, Dijkgraaf MGW, van Wijk MP, Bongers MEJ, Liem O, et al. Rectal Fecal Impaction Treatment in Childhood Constipation: Enemas Versus High Doses Oral PEG. Pediatrics 2009 Dec 1;124(6):e1108–15. Available from: https://publications.aap.org/pediatrics/article/124/6/e1108/72199/Rectal-Fecal-Impaction-Treatment-in-Childhood
13. Davis GR, Santa Ana CA, Morawski SG, Fordtran JS. Inhibition of water and electrolyte absorption by polyethylene glycol (PEG). Gastroenterology 1980 Jul;79(1):35–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7380220
14. Savino F, Viola S, Erasmo M, Di Nardo G, Oliva S, Cucchiara S. Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative. BMC Pediatr [Internet]. 2012 Nov 15;12:178. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23152962
15. Chen S-L, Cai S-R, Deng L, Zhang X-H, Luo T-D, Peng J-J, et al. Efficacy and complications of polyethylene glycols for treatment of constipation in children: a meta-analysis. Medicine (Baltimore) 2014 Oct;93(16):e65. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25310742
16. Tabbers MM, Dilorenzo C, Berger MY, Faure C, Langendam MW, Nurko S, et al. Evaluation and treatment of functional constipation in infants and children: Evidence-based recommendations from ESPGHAN and NASPGHAN. J Pediatr Gastroenterol Nutr 2014;58(2):258–74.
17. Abi-Hanna A, Lake AM. Constipation and encopresis in childhood. Pediatr Rev 1998 Jan;19(1):23–30; quiz 31. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9439166
18. Gleghorn EE, Heyman MB, Rudolph CD. No-Enema Therapy for Idiopathic Constipation and Encopresis. Clin Pediatr (Phila) 1991 Dec 2;30(12):669–72. Available from: http://journals.sagepub.com/doi/10.1177/000992289103001203
19. Schonwald A, Rappaport L. Consultation with the specialist: encopresis: assessment and management. Pediatr Rev 2004 Aug;25(8):278–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15286273
20. Staiano A, Del Giudice E. Colonic transit and anorectal manometry in children with severe brain damage. Pediatrics 1994 Aug;94(2 Pt 1):169–73. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8036068
21. Park ES, Park C Il, Cho S-R, Na S-I, Cho YS. Colonic transit time and constipation in children with spastic cerebral palsy. Arch Phys Med Rehabil 2004 Mar;85(3):453–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15031832